|
⚲
|
| Keyboard |
| Hamill John
✚
|
|
|---|---|
| CIK # | 0001559058 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001559058] | |
| 4 | [0001559058] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Hamill John | |
| NephroGenex Inc | |
| Savient Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
NephroGenex Inc NRX
Common Stock
|
2015-11-10 | Grant | 136,381 | $0.00 | |
|
NephroGenex Inc NRX
Options to Purchase Common Stock · derivative
|
2015-04-30 | Grant | 15,000 | $0.00 | |
|
NephroGenex Inc NRX
Options to Purchase Common Stock · derivative
|
2014-12-12 | Grant | 45,000 | $0.00 | |
|
NephroGenex Inc NRX
Options to Purchase Common Stock · derivative
|
2014-08-14 | Grant | 24,000 | $0.00 | |
|
NephroGenex Inc NRX
Options to Purchase Common Stock · derivative
|
2014-05-15 | Grant | 30,769 | $0.00 | |
|
Savient Pharmaceuticals Inc SVNT
Common Stock
|
2013-10-15 | Sell | 1,500 | $0.08 | 120 |
|
Savient Pharmaceuticals Inc SVNT
Common Stock
|
2013-10-15 | Sell | 7,646 | $0.08 | 612 |
|
Savient Pharmaceuticals Inc SVNT
Common Stock
|
2013-10-15 | Sell | 21,000 | $0.08 | 1,680 |
|
Savient Pharmaceuticals Inc SVNT
Common Stock
|
2013-10-15 | Sell | 1,000 | $0.08 | 80 |
|
Savient Pharmaceuticals Inc SVNT
Common Stock
|
2013-10-15 | Sell | 800 | $0.08 | 64 |
|
Savient Pharmaceuticals Inc SVNT
Common Stock
|
2013-10-15 | Sell | 5,000 | $0.08 | 400 |
|
Savient Pharmaceuticals Inc SVNT
Option to Purchase Common Stock · derivative
|
2013-03-05 | Grant | 110,000 | $0.00 | |
|
Savient Pharmaceuticals Inc SVNT
Option to purchase Common Stock, $0.01 par value · derivative
|
2012-09-24 | Grant | 250,000 | $2.92 | 730,000 |
|
Savient Pharmaceuticals Inc SVNT
Common Stock, $0.01 par value
|
2012-09-24 | Grant | 100,000 | $2.92 | 292,000 |